Q15109 (RAGE_HUMAN) Homo sapiens (Human)

Advanced glycosylation end product-specific receptor UniProtKBInterProSTRINGInteractive Modelling

404 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10); 1 identical sequence: Homo sapiens: A0A1U9X785

Available Structures

31 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the human RAGE ectodomain (VC1C2 fragment) in complex with human S100A6
4ybh
 Heteromer
P06703; 		23-322
14×ZN; 10×CL; 6×ACT; 4×CA;
Assess
Crystal structure of the human RAGE ectodomain (fragment VC1C2) in complex with mouse S100A6
4p2y
 Heteromer
P14069; 		23-321
6×ZN; 6×CL; 7×ACT; 2×CA;
Assess
The RAGE and HMGB1 complex
8i9m
 Heteromer
P09429; 		23-233
Assess
Structure of CEL-PEP-RAGE V domain complex
2l7u
 Heteromer
P02769; 		23-125
Assess
Structural Insights into Calcium Bound S100P - V Domain of the receptor for advanced glycation end …
2mjw
 Heteromer
P25815; 		23-121
Assess
Interaction of Human S100A6 (C3S) with V domain of Receptor for Advanced Glycation End products (RA…
2m1k
 Heteromer
P06703; 		23-121
Assess
RAGEC2-S100A13 tetrameric complex
2le9
 Heteromer
Q99584; 		235-327
Assess
X-ray structure of Ca(2+)-S100B with human RAGE-derived W72 peptide
5d7f
 Heteromer
P04271; 		70-79
4×CA; 6×GOL;
Assess
X-ray structure of Ca(2+)-S100B with human RAGE-derived W61 peptide
4xyn
 Heteromer
P04271; 		57-65
4×CA;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-((4-(4-carboxyphenoxy)…
6xq1
homo-4-mer23-231
14×ACT; 4×CL; 4×V74;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-(((3-(4-Carboxyphenoxy…
6xq3
homo-4-mer23-231
8×ACT; 4×CL; 8×V6Y;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 5
6xq7
homo-4-mer23-231
18×ACT; 4×CL; 14×V6V;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 1
6xq5
homo-4-mer23-231
14×ACT; 4×CL; 4×V6M;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 11
6xq8
homo-4-mer23-231
12×ACT; 4×V6M; 6×V6P; 4×CL;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 11
6xq6
homo-4-mer23-231
14×ACT; 4×CL; 6×V6P;
Assess
RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.
4oi8
homo-2-mer23-235
Assess
RAGE recognizes nucleic acids and promotes inflammatory responses to DNA
4oi7
homo-2-mer23-235
4×EDO;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-(((3-(4-Carboxyphenoxy…
7lml
homo-2-mer23-231
6×ACT; 2×CL; 8×Y6S;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-((4-(4-carboxyphenoxy)…
7lmw
homo-2-mer23-231
6×Y6P; 5×ACT; 1×CL;
Assess
Crystal structure of human rage ligand-binding domain
3cjj
monomer23-240
1×ACT; 4×ZN;
Assess
Refinement of RAGE-DNA complex in 3S59 without DNA
4of5
monomer23-233
Assess
Refinement of RAGE-DNA complex in 3S58 without DNA
4ofv
monomer23-233
Assess
Crystal structure of the full-length human RAGE extracellular domain (VC1C2 fragment)
4lp5
monomer23-233
Assess
Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE)
3o3u
monomer23-231
1×GLC; 1×SO4;
Assess
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 13
6xq9
monomer23-231
2×ACT; 2×V6S; 1×V6M;
Assess
Crystal structure of the human RAGE VC1 fragment in space group P62
4lp4
monomer23-231
1×NA;
Assess
Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal Derived A…
2mov
monomer23-125
1×IOR;
Assess
Solution Structure of Variable-type Domain of Human Receptor for Advanced Glycation Endproducts
2e5e
monomer23-121
Assess
Solution structure of the third ig-like domain from human Advanced glycosylation end product-specif…
2ens
monomer235-323
Assess
Structure of the C-terminal Domain of RAGE and Its Inhibitor
6vxg
monomer362-377
1×RQV;
Assess
Solution Structure of C-terminal RAGE (ctRAGE)
2lmb
monomer362-376
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4p2y.2.Gmonomer0.8023-321
100.00
Assess
4lp5.2.Amonomer0.7823-321
100.00
Assess
8i9m.1.Bmonomer0.5323-230
100.00
Assess

22 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24p2y.2.Gmonomer0.7723-281
91.12
Assess
Isoform 24lp5.2.Amonomer0.7423-281
91.12
Assess
Isoform 34p2y.2.Gmonomer0.8123-321
100.00
Assess
Isoform 34lp5.2.Amonomer0.7923-321
100.00
Assess
Isoform 34oi8.1.Ahomo-2-mer0.7823-228
100.00
Assess
Isoform 44p2y.2.Gmonomer0.7623-337
98.01
Assess
Isoform 44lp5.2.Amonomer0.7323-337
98.01
Assess
Isoform 52mov.1.Amonomer0.6623-117
93.68
Assess
Isoform 64p2y.2.Gmonomer0.7623-337
98.33
Assess
Isoform 64lp5.2.Amonomer0.7423-337
98.33
Assess
Isoform 74p2y.2.Gmonomer0.7923-307
97.89
Assess
Isoform 74lp5.2.Amonomer0.7723-307
97.89
Assess
Isoform 74oi8.1.Ahomo-2-mer0.7523-214
100.00
Assess
Isoform 84p2y.2.Gmonomer0.7723-305
89.75
Assess
Isoform 84lp5.2.Amonomer0.7423-305
89.75
Assess
Isoform 94oi8.1.Ahomo-2-mer0.7723-231
100.00
Assess
Isoform 94p2y.2.Gmonomer0.7123-330
90.78
Assess
Isoform 94lp5.2.Amonomer0.6923-330
90.78
Assess
Isoform 104p2y.2.Gmonomer0.8023-321
100.00
Assess
Isoform 104lp5.2.Amonomer0.7823-321
100.00
Assess
Isoform 108i9m.1.Bmonomer0.5323-230
100.00
Assess
Isoform 108dnn.1.Cmonomer0.5221-215
12.63
Assess